Cyrusone Inc (CONE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | 12-2010 | |
| Sales | 181,700 | 127,500 |
| Total expenses | 143,700 | 109,700 |
| Operating Income | 38,000 | 17,800 |
| Interest Expense | 32,900 | 11,500 |
| Other Income | -1,400 | 0 |
| Pre-tax Income | 3,700 | 6,300 |
| Income Tax | 2,200 | 2,700 |
| Net Income Continuous | 1,500 | 3,600 |
| Net Income Discontinuous | N/A | -100 |
| Net Income | $1,500 | $3,500 |
| EBITDA(a) | $93,500 | $54,000 |